Lombard Odier Asset Management (Switzerland) Sa Amicus Therapeutics, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.27 Billion
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $2.85 Million - $3.54 Million	261,592 New	261,592 $2.9 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$269 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

28.5M
Shares

$262 Million
0.05% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$224 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

24.2M
Shares

$223 Million
7.62% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$213 Million
3.18% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account